Pelthos Therapeutics Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | – | +1,473.6% | +3.8% | +203.5% | |
| – | – | +220.0% | -98.3% | -17,630.5% | |
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | – | – | – | -100.0% | |
| – | – | +91.7% | -58.1% | +5,421.0% | |
| – | +1.8% | -37.0% | +507.4% | +630.1% | |
| – | – | -25.0% | +909.4% | +4,098.4% | |
| – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.